Cargando…

Iron Chelator Induces Apoptosis in Osteosarcoma Cells by Disrupting Intracellular Iron Homeostasis and Activating the MAPK Pathway

Osteosarcoma is a common malignant bone tumor in clinical orthopedics. Iron chelators have inhibitory effects on many cancers, but their effects and mechanisms in osteosarcoma are still uncertain. Our in vitro results show that deferoxamine (DFO) and deferasirox (DFX), two iron chelators, significan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xue, Yanru, Zhang, Gejing, Zhou, Shoujie, Wang, Shenghang, Lv, Huanhuan, Zhou, Liangfu, Shang, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268062/ https://www.ncbi.nlm.nih.gov/pubmed/34281233 http://dx.doi.org/10.3390/ijms22137168

Ejemplares similares

Iron and leukemia: new insights for future treatments
por: Wang, Fang, et al.
Publicado: (2019)

Alterations in Cellular Iron Metabolism Provide More Therapeutic Opportunities for Cancer
por: Zhou, Liangfu, et al.
Publicado: (2018)

Iron-Chelating Agent Can Maintain Bone Homeostasis Disrupted by Iron Overload by Upregulating Wnt/Beta-Catenin Signaling
por: Xu, Wei, et al.
Publicado: (2020)

Intracellular Iron Chelation Modulates the Macrophage Iron Phenotype with Consequences on Tumor Progression
por: Mertens, Christina, et al.
Publicado: (2016)

Iron and Copper Intracellular Chelation as an Anticancer Drug Strategy
por: Gaur, Kavita, et al.
Publicado: (2018)

Iron Chelators in Treatment of Iron Overload
por: Entezari, Sarina, et al.
Publicado: (2022)

β-Phenethyl Isothiocyanate Induces Cell Death in Human Osteosarcoma through Altering Iron Metabolism, Disturbing the Redox Balance, and Activating the MAPK Signaling Pathway
por: Lv, Huanhuan, et al.
Publicado: (2020)

“Iron free” zinc oxide nanoparticles with ion-leaking properties disrupt intracellular ROS and iron homeostasis to induce ferroptosis
por: Zhang, Changping, et al.
Publicado: (2020)

Iron Homeostasis in the CNS: An Overview of the Pathological Consequences of Iron Metabolism Disruption
por: Porras, Christina A., et al.
Publicado: (2022)

Hinokitiol chelates intracellular iron to retard fungal growth by disturbing mitochondrial respiration
por: Jin, Xueyang, et al.
Publicado: (2021)

The Chelating Ability of Plant Polyphenols Can Affect Iron Homeostasis and Gut Microbiota
por: Scarano, Aurelia, et al.
Publicado: (2023)

Iron chelation and multiple sclerosis
por: Weigel, Kelsey J., et al.
Publicado: (2014)

Iron Chelation in Local Infection
por: Scott, Cassidy, et al.
Publicado: (2021)

Role of Iron Chelators in Mucormycosis
por: Mahalmani, Vidya, et al.
Publicado: (2021)

Conservative Iron Chelation for Neuroferritinopathy
por: Marchand, Felix, et al.
Publicado: (2022)

Modulation of iron homeostasis in macrophages by bacterial intracellular pathogens
por: Pan, Xin, et al.
Publicado: (2010)

Burkholderia pseudomallei modulates host iron homeostasis to facilitate iron availability and intracellular survival
por: Schmidt, Imke H. E., et al.
Publicado: (2018)

Enterobactin induces the chemokine, interleukin-8, from intestinal epithelia by chelating intracellular iron
por: Saha, Piu, et al.
Publicado: (2020)

Benefits of Iron Chelators in the Treatment of Parkinson’s Disease
por: Zeng, Xiaoyan, et al.
Publicado: (2021)

A Review on Iron Chelators in Treatment of Iron Overload Syndromes
por: Mobarra, Naser, et al.
Publicado: (2016)

High-Dose Deferoxamine Treatment Disrupts Intracellular Iron Homeostasis, Reduces Growth, and Induces Apoptosis in Metastatic and Nonmetastatic Breast Cancer Cell Lines
por: Bajbouj, Khuloud, et al.
Publicado: (2018)

The Utility of Iron Chelators in the Management of Inflammatory Disorders
por: Lehmann, C., et al.
Publicado: (2015)

A Speciation Study on the Perturbing Effects of Iron Chelators on the Homeostasis of Essential Metal Ions
por: Crisponi, Guido, et al.
Publicado: (2015)

Iron Homeostasis Disruption and Oxidative Stress in Preterm Newborns
por: Raffaeli, Genny, et al.
Publicado: (2020)

Iron chelation effect of curcumin and baicalein on aplastic anemia mouse model with iron overload
por: Dijiong, Wu, et al.
Publicado: (2019)

Iron Chelator or Iron Supplement Consumption in COVID-19? The Role of Iron with Severity Infection
por: Bastin, Alireza, et al.
Publicado: (2021)

Natural flavonoids disrupt bacterial iron homeostasis to potentiate colistin efficacy
por: Zhong, Zi-xing, et al.
Publicado: (2023)

Objectives and Methods of Iron Chelation Therapy
por: Hershko, C., et al.
Publicado: (2003)

Iron Chelation Therapy in Thalassemia Syndromes
por: Cianciulli, Paolo
Publicado: (2009)

Iron Chelation Therapy in Myelodysplastic Syndromes
por: Messa, Emanuela, et al.
Publicado: (2010)

Myelodysplastic Syndromes and Iron Chelation Therapy
por: Angelucci, Emanuele, et al.
Publicado: (2017)

Iron chelation in treatment of superficial siderosis
por: Derle, Eda
Publicado: (2018)

Reversing oncogenic transformation with iron chelation
por: Abdelaal, Gina, et al.
Publicado: (2021)

Emerging Roles of the Iron Chelators in Inflammation
por: Di Paola, Alessandra, et al.
Publicado: (2022)

Prion protein modulates glucose homeostasis by altering intracellular iron
por: Ashok, Ajay, et al.
Publicado: (2018)

The Interplay between Intracellular Iron Homeostasis and Neuroinflammation in Neurodegenerative Diseases
por: Lee, Jaewang, et al.
Publicado: (2023)

Magneto-mechanical stimulation modulates osteocyte fate via the ECM-integrin-CSK axis and wnt pathway
por: Zhang, Bin, et al.
Publicado: (2023)

Therapeutic Potential of Iron Chelating Therapy: Modification of Disease by Iron Depletion
por: Hershko, Chaim, et al.
Publicado: (1994)

Iron Chelation Therapy with Deferasirox in the Management of Iron Overload in Primary Myelofibrosis
por: Elli, Elena Maria, et al.
Publicado: (2014)

Korean Guideline for Iron Chelation Therapy in Transfusion-Induced Iron Overload
por: Jang, Jun Ho, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_7ruq2ambb6kon0ji2kleb2dl1m